Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Structurally-modified antibody – immunoglobulin – or fragment...
Reexamination Certificate
2005-06-14
2005-06-14
Harris, Alana M. (Department: 1642)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Structurally-modified antibody, immunoglobulin, or fragment...
C424S130100, C424S145100, C424S185100, C435S326000, C436S086000, C436S087000, C514S001000, C530S300000, C530S350000, C530S385000, C530S386000, C530S387100, C530S387300, C530S388100, C530S389200
Reexamination Certificate
active
06905684
ABSTRACT:
Preventives and remedies for diffuse lung diseases whereby apoptosis can be inhibited and thus favorable preventive/therapeutic effects can be established.These drugs contain apoptosis-inhibiting substances as the active ingredient.The above apoptosis-inhibiting substances include Fas antagonists and Fas/Fas ligand binding inhibitors such as Fas derivatives and anti-Fas ligand antibodies.
REFERENCES:
patent: 6114507 (2000-09-01), Shirakawa et al.
patent: 0675200 (1995-10-01), None
patent: 0842948 (1998-05-01), None
patent: 0965637 (1999-12-01), None
patent: WO9513293 (1995-05-01), None
patent: WO9702290 (1997-01-01), None
patent: WO9742319 (1997-11-01), None
Aoshiba et al. The Fas/Fas-ligand system is not requried for bleomycin-induced pulmonary fibrosis in mice. American Journal of Respiratory and Critical Care Medicine 162:659-700, 2000.
Merriam-Webster's Collegiate Dictionary, tenth edition. 1996.
Hagimoto et al. Apoptosis and Expression of Fas/Fas Ligand mRNA in Bleomycin-induced Pulmonary Fibrosis in Mice. Am. J. Resp. Cell Mol. Biol. 16:91-101, 1997.
Hagimoto et al., Am. J. Respir. Cell Mol. Biol., vol. 16, p. 91-101 (1997).
Hagimoto et al., Am. J. Respir. Cell Mol. Biol., vol. 17, p. 272-278 (1997).
Yaekashiwa et al., Am. J. Respir. Crit. CareMed., vol. 156, p. 1937-44 (1997).
Kazufumi et al., Microscopy Research and Technique, vol. 38, pp. 480-487 (1997).
Milik, A.M. et al., J. of Clinical Investigation, vol. 99, No. 5 (1997) pp. 1082-1091.
Program of 17th Meeting Japanese Society of Inflammations, p. 130, No. 16 (1996) and concise English translation.
Birch & Stewart Kolasch & Birch, LLP
Harris Alana M.
Mochida Pharmaceutical Co. Ltd.
LandOfFree
Preventives and remedies for diffuse lung diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Preventives and remedies for diffuse lung diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preventives and remedies for diffuse lung diseases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3471523